LBA10Primary results of ALESIA: A randomised, phase III, open-label study of alectinib vs crizotinib in Asian patients with treatment-naïve ALK+ advanced NSCLC

Published 2018 View Full Article

Authors

Keywords

Journal

ANNALS OF ONCOLOGY

Volume 29, Issue suppl_8, Pages -

Publisher

Oxford University Press (OUP)

Online

2018-10-25

DOI

10.1093/annonc/mdy424.062

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started

ANNALS OF ONCOLOGY

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Discover Peeref hubs

Ask a Question. Answer a Question.